MON-603 Racial Distribution of Endocrine Complications in Oncology Patients Treated with Immune Checkpoint Inhibitors

Background: Immune-related adverse events (irAEs) have been frequently described with the growing use of immune checkpoint inhibitors (ICI) in cancer treatment. While many autoimmune diseases are known to be more prevalent in certain racial groups, it is unknown if there are racial disparities in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Danielle, Leiter, Amanda, Carroll, Emily, Ben Shimol, Jennifer, Eisenberg, Elliot, Galsky, Matthew, Gallagher, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550805/
http://dx.doi.org/10.1210/js.2019-MON-603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550805/
http://dx.doi.org/10.1210/js.2019-MON-603

Ejemplares similares